is it safe to switch from semaglutide to tirzepatide vs. Semaglutide: What You Should Know Switching From Semaglutide To Tirzepatide
Description
Tirzepatide acts as a GLP-1 receptor agonist and also has actions on the GIP receptor, which contributes to glucose regulation and weight reduction
New trial data for Amgen's GLP-1 drug MariTide shows a weight loss of 20 percent in non-diabetic participants with obesity or overweight.
The present study aims to investigate whether semaglutide, a long-acting GLP1R agonist, can ameliorate cardiac hypertrophy induced by pressure overload, and explore the potential mechanism
Use these tips from WeGoTogether to stay supported
